Skip to main content
PharmAbcine Inc. logo

PharmAbcine Inc. — Investor Relations & Filings

Ticker · 208340 ISIN · KR7208340000 KO Manufacturing
Open in API
Filings indexed 461 across all filing types
Latest filing 2021-05-14 Annual Report
Country KR South Korea
Listing KO 208340

About PharmAbcine Inc.

http://pharmabcine.com/

PharmAbcine Inc. is a clinical-stage biotechnology company specializing in the development of fully human therapeutic monoclonal antibodies (mAbs). The company focuses on creating innovative treatments for diseases with high unmet medical needs, primarily in oncology, neovascular eye diseases, and other inflammatory and vascular disorders. Utilizing its proprietary human antibody library and discovery technologies, PharmAbcine advances a pipeline of next-generation IgG-based therapeutics. The company's mission is to contribute to human health by providing novel antibody-based drugs to patients.

Recent filings

Filing Released Lang Actions
[기재정정]사업보고서 (2017.12)
Annual Report Classification · 95% confidence The document is a 'Correction Report' (정정신고) for a previously filed 'Business Report' (사업보고서), which is the Korean equivalent of an Annual Report (10-K). The document contains detailed corporate information, history, shareholder structure, and capital changes for the fiscal year 2017. Although it is a correction, it functions as the primary annual disclosure document for the company. Following the classification guidelines, this is categorized as an Annual Report (10-K). FY 2017
2021-05-14 Korean
[기재정정]분기보고서 (2016.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'PharmAbcine Inc.' (주식회사 파멥신). It contains detailed financial information, business descriptions, management discussions, and shareholder information for the period ending September 30, 2016. It is a comprehensive financial report rather than a mere announcement or certification. 9M 2016
2021-05-14 Korean
[기재정정]분기보고서 (2018.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'PharmAbcine Inc.' (주식회사 파멥신). It contains detailed financial and business information, including company history, capital changes, and management discussions for the period ending March 31, 2018. Although it mentions a 'correction' (정정신고), it is a comprehensive financial report rather than a simple announcement or certification. Therefore, it is classified as an Interim/Quarterly Report. Q1 2018
2021-05-14 Korean
[기재정정]반기보고서 (2018.06)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Semi-Annual Report' (반기보고서) for the company PharmAbcine (주식회사 파멥신) for the period ending June 30, 2018. It contains detailed corporate information, history, capital changes, and business descriptions. Although it includes a 'Correction Report' (정정신고) header, the content is a comprehensive interim financial report. According to the filing definitions, a comprehensive financial report for a period shorter than a full fiscal year is classified as an Interim/Quarterly Report (IR). H1 2018
2021-05-14 Korean
[기재정정]분기보고서 (2018.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company 'PharmAbcine' (파멥신). It contains detailed financial data, business operations, capital changes, and management information for the period ending September 30, 2018. Although it mentions a 'correction' (정정신고), it is a comprehensive financial report for a period shorter than a full fiscal year, which fits the definition of an Interim/Quarterly Report (IR). 9M 2018
2021-05-14 Korean
[기재정정]사업보고서 (2018.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) filed by PharmAbcine (파멥신) for the fiscal year ending December 31, 2018. It contains detailed corporate information, history, capital changes, and shareholder information. In the South Korean regulatory context (DART system), a 'Business Report' (사업보고서) is the equivalent of an Annual Report (10-K). FY 2018
2021-05-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.